DHL Group shows confidence in India with investments of around EUR 1 billion in the country until 2030
4 Dec 20257 min read
Summary
- DHL commits around EUR 1 billion to expand sustainable, tech-enabled logistics in India, driven by confidence in India’s economic growth, trade diversification, and increasing global connectedness.
- Major investments target high-growth sectors including life sciences and healthcare (new cold chain facilities and logistics platforms), new energy (EV and battery Logistics Center of Excellence), and e-commerce infrastructure via Blue Dart.
- DHL advances its Strategy 2030 pillars through fleet electrification, renewable-energy sites, GoGreen Plus sustainable fuel programs, and expanded digital innovation hubs, positioning India as a key center for green logistics and technology development.
Bonn/Mumbai, November 13, 2025: DHL Group, the world’s leading logistics company,announced plans for investments of around EUR 1 billion across all its business units in India by 2030. This significant commitment underscores the company’s confidence in India as a key growth market and reflects its Strategy 2030 – Accelerate sustainable growth. The multi-year investment program spans key sectors including life sciences and healthcare, new energy, e-commerce, and digitalization. Major infrastructure developments include:• India’s largest low carbon-emission integrated operating facility for Blue Dart in Bijwasan• First automatic sorting center for DHL Express India in DelhiFifth DHL IT Services Center in Indore• Electric Vehicle (EV) and Battery Logistics Center of Excellence (COE) in Chennai and Mumbai• Largest low greenhouse gas (GHG) emission integrated ground hub for Blue Dart in Haryana
“
“Global trade is facing headwinds, but we remain confident in India’s dynamic market. The country’s diversification strategy and business-friendly policies provide a solid foundation for long-term investments. With our investment program of around EUR 1 billion, we are expanding reliable and more sustainable logistics solutions for our customers in India,” said Tobias Meyer, CEO of DHL Group.
Life Sciences and Healthcare
India has long established a leading position in the life sciences and healthcare (LSHC) sector, becoming a global hub for contract manufacturing, research and development, and clinical trials. It is also a global leader in generic pharmaceuticals, producing over 50% of the world’s vaccines.
Members Only Content
To read the full article and access exclusive content, please login or register as a member.
Member Benefits:
- • Full access to all articles
- • Exclusive industry insights
- • Apply Supply Chain jobs in asia